10272-06-7 Usage
Description
3-Chloro-5-methoxyaniline is an organic compound that serves as a key intermediate in the synthesis of various pharmaceutical products. It is characterized by the presence of a chloro substituent at the 3-position and a methoxy group at the 5-position on the aniline backbone, which contributes to its reactivity and potential applications in medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
3-Chloro-5-methoxyaniline is used as a synthetic intermediate for the preparation of a range of pharmaceutical goods. Its unique chemical structure allows it to be a versatile building block in the development of new drugs, particularly those targeting specific biological pathways or receptors.
In the synthesis of pharmaceuticals, 3-chloro-5-methoxyaniline can be further modified or combined with other chemical entities to create active pharmaceutical ingredients (APIs) with desired therapeutic properties. Its presence in the final drug product may contribute to the drug's efficacy, safety, and pharmacokinetic profile, making it an important component in the drug discovery and development process.
Check Digit Verification of cas no
The CAS Registry Mumber 10272-06-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,0,2,7 and 2 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 10272-06:
(7*1)+(6*0)+(5*2)+(4*7)+(3*2)+(2*0)+(1*6)=57
57 % 10 = 7
So 10272-06-7 is a valid CAS Registry Number.
InChI:InChI=1/C7H8ClNO/c1-10-7-3-5(8)2-6(9)4-7/h2-4H,9H2,1H3
10272-06-7Relevant articles and documents
COMPOUNDS, COMPOSITIONS AND METHODS OF USE
-
Page/Page column 107, (2020/07/06)
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.
Oxalic amide ligands, and uses thereof in copper-catalyzed coupling reaction of aryl halides
-
Page/Page column 89-90, (2020/01/09)
The present invention provides oxalic amide ligands and uses thereof in copper-catalyzed coupling reaction of aryl halides. Specifically, the present invention provides a use of a compound represented by formula I, wherein definitions of each group are described in the specification. The compound represented by formula I can be used as a ligand in copper-catalyzed coupling reaction of aryl halides for the formation of C—N, C—O and C—S bonds.
QUINUCLIDINES FOR MODULATING ALPHA 7 ACTIVITY
-
, (2016/02/29)
Provided are substituted quinuclidine compounds, pharmaceutical compositions comprising such compounds, and methods of modulating α7 nicotinic acetylcholine receptors and treating neurological disorders using such compounds.